Nuzenio

Polycythemia Vera The

Polycythemia Vera The news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 8 latest news signals 7 publisher sources 100/100 entity strength

Latest news

Silence Therapeutics trial cuts phlebotomies to 0.2 per patient - Stock TitanStock Titan · Mon, 10 Aug 2026 11:33:40 GMTSilence Therapeutics aims at Takeda with new data in rare blood cancer - STATSTAT · Mon, 10 Aug 2026 11:33:33 GMTSilence brings the noise to Takeda with phase 2 blood cancer win - Fierce BiotechFierce Biotech · Mon, 10 Aug 2026 11:31:00 GMTSilence spells out Phase 2 success for gene-silencing drug in rare blood cancer - Endpoints NewsEndpoints News · Mon, 10 Aug 2026 11:31:00 GMTSilence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera - The AI JournalThe AI Journal · Mon, 10 Aug 2026 09:14:10 GMTPolycythemia Vera Prevalence to Near 100K by 2030 as Symptom Burden Grows - The American Journal of Managed CareThe American Journal of Managed Care · Sun, 09 Aug 2026 16:17:00 GMTReal-World Polycythemia Care Often Fails to Control Hematocrit - The American Journal of Managed CareThe American Journal of Managed Care · Thu, 06 Aug 2026 17:55:08 GMTSapablursen Represents Potential Avenue for Improved Hepcidin Production in Polycythemia Vera - OncLiveOncLive · Mon, 03 Aug 2026 18:11:54 GMT

Timeline

Mon, 10 Aug 2026 11:33:40 GMTSilence Therapeutics trial cuts phlebotomies to 0.2 per patient - Stock Titan
Mon, 10 Aug 2026 11:33:33 GMTSilence Therapeutics aims at Takeda with new data in rare blood cancer - STAT
Mon, 10 Aug 2026 11:31:00 GMTSilence brings the noise to Takeda with phase 2 blood cancer win - Fierce Biotech
Mon, 10 Aug 2026 11:31:00 GMTSilence spells out Phase 2 success for gene-silencing drug in rare blood cancer - Endpoints News
Mon, 10 Aug 2026 09:14:10 GMTSilence Therapeutics to Host Conference Call and Webcast to Discuss Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera - The AI Journal
Sun, 09 Aug 2026 16:17:00 GMTPolycythemia Vera Prevalence to Near 100K by 2030 as Symptom Burden Grows - The American Journal of Managed Care

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Polycythemia Vera The.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

7 distinct publisher/source names are currently connected to this entity page.